The information contained within
this announcement is deemed to constitute inside information as
stipulated under the retained EU law version of the Market Abuse
Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law
by virtue of the European Union (Withdrawal) Act 2018. The
information is disclosed in accordance with the Company's
obligations under Article 17 of the UK MAR. Upon the publication of
this announcement, this inside information is now considered to be
in the public domain.
24 June 2024
Eden Research
Plc
("Eden"
or "Company")
Biofungicide Label Extension
in Spain
Eden Research plc (AIM: EDEN), the
AIM-quoted company focused on sustainable biopesticides and
plastic-free formulation technologies for use in the global crop
protection, animal health and consumer products industries,
announces that its flagship biofungicide has received authorisation
for use in new crops and fungal pathogens in Spain.
Mevalone®, marketed as
Araw® in Spain by Sipcam Iberia ("Sipcam"), Eden's
commercial partner in Spain, Portugal and several other countries,
will now be permitted for use against powdery mildew on 22 new
crops, botrytis cinerea on 20 new crops, rust disease on 8 new
crops, and sclerotinia on 4 new crops. These new horticultural
crops include a wide range of species such as avocados, kiwis,
mangos, cherries, chickpeas, green beans, asparagus, leeks, and
artichokes.
Araw has been a well-established
solution to prevent botrytis in grapes since it was launched in
Spain in 2016. Following the first label expansion in 2021, Araw
has become the reference biofungicide in a wide range of
horticultural crops and berries, including blueberry, tomato,
cucumber and lettuce.
Araw helps growers to meet the
highest quality standards and a large percentage of this produce is
exported to other EU countries, as well as the UK and other premium
markets. This has led to a significant increase in the
commercialised volumes of Araw sold in Spain in recent years.
This newly expanded label makes Araw
one of the most versatile and reliable solutions to prevent fungal
diseases in many crops under organic and conventional agriculture.
Thanks to this new authorisation, obtained through Sipcam's local
regulatory team, all relevant horticultural crops in Spain can now
be protected with Araw representing an excellent opportunity in
several crops of growing importance, such as avocado, mango, and
almond, which has become the third largest tree crop in Spain after
olives and grapes. Spain boasts the largest cultivated area of
almond trees in the world and ranks third in terms of overall
production. Eden anticipates that this growth of the addressable
market for Araw will contribute to revenue in 2025 and beyond.
Further details of this expansion will be provided in due course as
commercialisation commences.
Sean Smith, Chief Executive Officer of Eden Research,
commented:
"Today's announcement is an
excellent demonstration of our strategy to pursue growth
opportunities through both new product introductions and with
existing products by targeting new crop types and new disease
targets. We are delighted to build on the success of our
longstanding relationship with Sipcam. They have done an
outstanding job of making the Iberian region an important and
strong revenue-generating territory for the Company. This label
extension represents a significant additional growth opportunity
for us. It not only includes numerous new crops and diseases, but
it also includes a number of high-value crops that are particularly
disease prone."
For further information
contact:
Eden
Research plc
|
|
Sean Smith
Alex Abrey
|
www.edenresearch.com
01285 359
555
|
|
|
Cavendish Capital Markets Limited (Nominated advisor and
broker)
|
|
Giles Balleny / George
Lawson (corporate finance)
Charlie Combe (corporate broking)
Michael Johnson (sales)
|
020 7220
0500
|
|
|
Hawthorn Advisors (Financial PR)
|
|
Victoria Ainsworth
|
eden@hawthornadvisors.com
|
Notes to Editors:
Eden
Research is the
only UK-listed company focused on biopesticides for
sustainable agriculture. It develops and supplies innovative
biopesticide products and natural microencapsulation technologies
to the global crop protection, animal health and consumer products
industries.
Eden's products are formulated with
terpene active ingredients, based on natural plant defence
metabolites. To date, they have been primarily used on high-value
fruits and vegetables, improving crop yields and marketability,
with equal or better performance when compared with conventional
pesticides. Eden has three products currently on the
market:
Based on plant-derived active
ingredients, Mevalone® is a foliar biofungicide which
initially targets a key disease affecting grapes and other
high-value fruit and vegetable crops. It is a useful
tool in crop defence programmes and is aligned with the
requirements of integrated pest management programmes. It is
approved for sale in a number of key countries whilst Eden and its
partners pursue regulatory clearance in new territories thereby
growing Eden's addressable market globally.
Cedroz™ is a
bionematicide that targets free living nematodes which are
parasitic worms that affect a wide range of high-value fruit and
vegetable crops globally. Cedroz is registered for sale on
two continents and Eden's commercial collaborator, Eastman
Chemical, is pursuing registration and commercialisation of this
important new product in numerous countries globally.
Eden's seed treatment
product, Ecovelex was developed to safely
tackle crop destruction caused by birds - a major cause of losses
in maize and other crops. Ecovelex works by creating an
unpleasant taste or odour that repels birds, leaving the seeds
safely intact and the birds unaffected and free to find alternative
food sources. The product is based on Eden's plant-derived
chemistry, registered in the EU, U.S. and elsewhere, and formulated
using Eden's Sustaine® microencapsulation system.
Eden's Sustaine® encapsulation
technology is used to harness the biocidal efficacy of naturally
occurring chemicals produced by plants (terpenes) and can also be
used with both natural and synthetic compounds to enhance their
performance and ease-of-use. Sustaine microcapsules are
naturally-derived, plastic-free, biodegradable micro-spheres
derived from yeast. It is one of the only viable, proven and
immediately registerable solutions to the microplastics problem in
formulations requiring encapsulation.
Eden was admitted to trading on AIM
on 11 May 2012 and trades under the symbol EDEN. It was
awarded the London Stock Exchange Green Economy Mark in January
2021, which recognises London-listed companies that derive
over 50% of their total annual revenue from products and services
that contribute to the global green economy. Eden derives 100% of
its total annual revenues from sustainable products and
services.
For more information about Eden,
please visit: www.edenresearch.com.